Securities
Issues & Trends
VALOFE Successfully Concludes 'Last Origin' Pop-Up Store… Plans to Expand IP Business
Global game publishing platform company VALOFE(331520)announced on the 12th that it successfully concluded its "Last Origin" pop-up store and collaboration café, held at V-Square in Konkuk University,…
- 2026-08-12 10:31:12
- Kim Hyung-il
Issues & Trends
GENOLUTION INC. CEO Kim Ki-ok Buys 36,000 Shares of Company Stock Following Change in Largest Shareholder
Genolution ( GENOLUTION INC.(225220)), a company specializing in green biotechnology, announced on the 12th that Co-CEO Kim Ki-ok purchased an additional 36,938 shares of the company’s stock on the op…
- 2026-08-12 10:28:17
- Kim Hyung-il
Issues & Trends
MIRAE ASSET SECURITIES Reports 1.9 Trillion Won in Second-Quarter Net Profit… First in the Industry to Post 1 Trillion Won in Net Profit for Two Consecutive Quarters
MIRAE ASSET SECURITIES ( MIRAE ASSET SECURITIES(006800)) announced on the 12th that it posted a consolidated net profit of 1.9052 trillion won for the second quarter of this year. Following a net prof…
- 2026-08-12 09:58:32
- Kwon Oh Seok
Issues & Trends
UNI CHEM.CO.,LTD: “Expect Mass Production Revenue from Humanoid e-Skin to Come Sooner Than Expected”
As the competition in humanoid robotics expands beyond “how well they move” to “how precisely they sense their surroundings,” UNI CHEM.CO.,LTD(011330)is accelerating the commercialization of its elect…
- 2026-08-12 09:50:36
- Shin Ha-yeon
Issues & Trends
A World Apart from the Rising Retail Investors… Stocks Picked by ‘Big Player’ BlackRock
Amid rising volatility in the domestic stock market and a continued exodus of retail investors, BlackRock, the world’s largest asset manager, has been steadily acquiring stakes in South Korean listed …
- 2026-08-12 09:35:04
- Hur Jieun
Issues & Trends
Curiosis Inc. Enters the Organoid Drug Evaluation Market… Signs MOU with Gradiant BioConvergence
#Curiosis Inc., a company specializing in lab automation and live-cell imaging, announced on the 12th that it is expanding its business scope into the field of organoid (PDO)-based drug evaluation. Or…
- 2026-08-12 09:10:57
- Kim Hyung-il
Issues & Trends
SAMG ENTERTAINMENT CO.,LTD to Hold Encore Performances of the Show Musical "Princess Catch! Tinipping" in Seoul and Daegu
Global IP content company SAMG ENTERTAINMENT CO.,LTD(419530)(SAMG ENTERTAINMENT CO.,LTD) is set to kick off its nationwide tour in the second half of the year with its show musical “Princess Catch! Ti…
- 2026-08-12 09:07:04
- Kwon Oh Seok
Issues & Trends
S2W Inc. Participates in the Production of Interpol’s ‘Africa Cyber Threat Report’
S2W Inc., a big data analytics and artificial intelligence (AI) company, announced on the 12th that it participated as a private-sector partner in the production of the “African Cyberthreat Assessment…
- 2026-08-12 09:01:12
- Shin Ha-yeon
Issues & Trends
"Incross Co.,Ltd. Transforms from a Media Agency into an AI Data Intelligence Company"
On the 12th, independent research firm Value Finder assessed that Incross Co.,Ltd.(216050)is undervalued, trading at a P/E ratio of just 5.3x despite holding abundant cash and cash equivalents equival…
- 2026-08-12 08:54:51
- Kwon Oh Seok
Issues & Trends
L&C BIO Secures Four-Year Clinical Trial Results for 'Megacarti,' a Knee Cartilage Treatment
L&C Bio ( L&C BIO(290650)), a human tissue-based regenerative medicine company, announced on the 12th that it has secured four-year mid-to-long-term clinical follow-up data for its knee cartilage trea…
- 2026-08-12 08:42:23
- Kim Hyung-il
PHARM EDAILY
Shorts